COPT Defense Properties, an S&P MidCap 400 Company (CDP) Fair Value & Analysis
Real Estate · US · Market cap $3.9B
Fair value as of: Jun 25, 2026
Analysis
COPT Defense Properties, an S&P MidCap 400 Company (CDP) currently trades at $34.97, while our model-based Fair Value estimate is $22.84 — implying the stock looks roughly 34.7% overvalued today. We read business quality at 93/100 (high quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
COPT Defense Properties, an S&P MidCap 400 Company, is a self-managed REIT focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government defense installations and missions (referred to as its Defense/IT Portfolio). The Company's tenants include the USG and their defense contractors, who are primarily engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. As of March 31, 2026, the Company's Defense/IT Portfolio of 201 properties, including 24 owned through unconsolidated joint ventures, encompassed 23.2 million square feet and was 96.4% leased. COPT Defense Properties was incorporated in 1988 and is based in Columbia, United States.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is COPT Defense Properties, an S&P MidCap 400 Company (CDP) undervalued?
What is the fair value of CDP?
What is the quality score of CDP?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.